Detalhe da pesquisa
1.
The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection.
J Viral Hepat
; 21(8): 568-77, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24118177
2.
Recipient IL28B polymorphism is an important independent predictor of posttransplant diabetes mellitus in liver transplant patients with chronic hepatitis C.
Am J Transplant
; 12(3): 737-44, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22300408
3.
Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study.
Osteoporos Int
; 22(3): 903-10, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20585937
4.
Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for hepatitis C.
Am J Transplant
; 9(6): 1406-13, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19459812
5.
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection.
Am J Transplant
; 8(11): 2426-33, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18727694
6.
Dynamic decision analysis to determine optimal treatment duration in chronic hepatitis C.
Aliment Pharmacol Ther
; 21(5): 539-47, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15740537
7.
The treatment of hepatitis C: history, presence and future.
Neth J Med
; 62(3): 76-82, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15209471
8.
Hepatitis C 2002 guidelines: summary and annotations.
Scand J Gastroenterol Suppl
; (239): 105-10, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14743892
9.
Letter: scoring models in alcoholic hepatitis.
Aliment Pharmacol Ther
; 42(1): 126, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26040528
10.
Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy.
Gut
; 53(10): 1504-8, 2004 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-15361504